Vincristine (NSC 67574) in non-small cell bronchogenic carcinoma. Results of a phase II clinical study-Reference-Cited by-同舟云学术

Vincristine (NSC 67574) in non-small cell bronchogenic carcinoma. Results of a phase II clinical study

Published:1978-05 Issue:5 Volume:14 Page:501-505
ISSN:0014-2964
Container-title:European Journal of Cancer (1965)
language:en
Short-container-title:European Journal of Cancer (1965)

Author:

Brugarolas A.,Lacave A.J.,Ribas A.,Miralles M.T.Garcia

Publisher

Elsevier BV

Subject

General Medicine

Reference8 articles.

1. Polychemotherapy with adriamycin (NSC 123127) in bronchogenic carcinoma;Selawry;Cancer Chemother. Rep.,1975

2. Clinical evaluation of vincristine (NSC 67574);Shaw;Cancer Chemother. Rep.,1964

3. Single Agents in Cancer Chemotherapy;Livingstone,1970

4. Vincristine (NSC-67574) in the treatment of small cell anaplastic carcinoma of the lung;Dombernowsky;Cancer Treat. Rep.,1976

5. Y. Kenis and I. D. Minna, Prospects for cure of small cell sarcinoma. Second National Cancer Institute Conference on Lung Cancer Treatment. Airlie House, Virginia. To be published.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience;Open Heart;2021-12

2. Microtubule Inhibitors and Cardiotoxicity;Current Oncology Reports;2021-02-13

3. Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics;JACC: CardioOncology;2019-12

4. A New In Vitro Screening System for Anticancer Drugs for the Treatment of Non-Small Cell Lung Cancer;Selective Cancer Therapeutics;1989-01

5. Vinca alkaloids in the treatment of non-small cell lung cancer;Cancer Treatment Reviews;1987-03